Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 AUD | +0.38% | -2.22% | +11.86% |
Apr. 16 | XRF Scientific's Profit Before Tax Rises 15% in March Quarter | MT |
Feb. 20 | XRF Scientific Shares Decline 5% Despite Higher Fiscal H1 Revenue, EPS | MT |
Sales 2024 * | 59.1M 38.96M | Sales 2025 * | 63.8M 42.05M | Capitalization | 182M 120M |
---|---|---|---|---|---|
Net income 2024 * | 8M 5.27M | Net income 2025 * | 10M 6.59M | EV / Sales 2024 * | 2.9 x |
Net cash position 2024 * | 10.9M 7.18M | Net cash position 2025 * | 15.4M 10.15M | EV / Sales 2025 * | 2.62 x |
P/E ratio 2024 * |
20.3
x | P/E ratio 2025 * |
18.1
x | Employees | 48 |
Yield 2024 * |
2.35% | Yield 2025 * |
2.65% | Free-Float | 64.41% |
1 day | +0.38% | ||
1 week | -2.22% | ||
Current month | -2.22% | ||
1 month | -0.75% | ||
3 months | +10.00% | ||
6 months | +16.81% | ||
Current year | +11.86% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08-05-31 | |
Andrew Watson
DFI | Director of Finance/CFO | - | 13-08-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Grimwade
CHM | Chairman | 66 | 12-04-30 |
David Kiggins
BRD | Director/Board Member | 54 | 12-04-30 |
David Brown
BRD | Director/Board Member | 86 | 04-06-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.32 | +0.38% | 145,774 |
24-06-06 | 1.315 | -1.87% | 221,986 |
24-06-05 | 1.34 | -1.83% | 160,561 |
24-06-04 | 1.365 | +1.49% | 81,013 |
24-06-03 | 1.345 | -0.37% | 129,052 |
Delayed Quote Australian S.E., June 07, 2024 at 01:47 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.86% | 120M | |
+26.27% | 28.39B | |
+35.87% | 5.54B | |
+33.66% | 4.91B | |
+17.51% | 1.51B | |
+6.64% | 1.06B | |
-27.99% | 929M | |
-47.61% | 730M | |
+2.27% | 442M | |
-15.98% | 335M |
- Stock Market
- Equities
- XRF Stock